Itrasys CF 200 Capsule contains Itraconazole 200 mg, a broad-spectrum triazole antifungal agent used for the treatment of various systemic and superficial fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. It is effective against a wide range of pathogenic fungi, including Candida species, Aspergillus species, and dermatophytes. Itrasys CF 200 is indicated for the management of invasive aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and other fungal infections resistant to conventional therapy. The capsule formulation ensures optimal bioavailability when taken with food, enhancing absorption. Dosage and duration of therapy depend on the type and severity of infection and should be determined by a healthcare professional. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, as well as headache and rash. Caution is advised in patients with hepatic impairment, and liver function tests should be monitored during prolonged therapy. Itrasys CF 200 may interact with several drugs metabolized by the cytochrome P450 system; therefore, a thorough medication review is essential before initiating treatment. This medication should be used under strict medical supervision to ensure safety and efficacy.